Report on the Belgian consensus meeting on Colorectal cancer screening

被引：0

作者：

Adler, M

De Vos, M

Dufour, A

Janssens, J

Laurent, S

Melange, M

Polus, M

Op de Beeck, B

Schapira, M

Van Cutsem, E

Van Gossum, A

机构：

[1] ULB, Erasmus Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium

[2] State Univ Ghent Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium

[3] Soc Sci Med Gen, Brussels, Belgium

[4] Dept Gastroenterol, St Elisabeth, Turnhout, Belgium

[5] UCL, Clin Univ St Luc, Dept Gastroenterol, Brussels, Belgium

[6] UCL, Univ Hosp, Dept Gastroenterol, Mont Godinne, Belgium

[7] CHU Sart Timan, Dept Gastroenterol, Liege, Belgium

[8] UZA Antwerpen, AZ VUB Brussels, Dept Radiol, Antwerp, Belgium

[9] CH Jolimont, Dept Gastroenterol, La Louviere, Belgium

[10] KUL, UZ Gasthuisberg, Dept Gastroenterol, Louvain, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2005年 / 68卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Screening and prevention of colorectal cancer must be a public health priority. It is the most frequent malignancy in Europe, the second leading cause of cancer death, including Belgium where more than 6.000 new cases occur per year. Various screening modalities, from non invasive to invasive are available and currently in use and they are all cost-effective in comparison with no screening. The decision as to which screening test to use should be made by the patient and clinician. Consensus documents prepared by the Belgian scientific community appear in this issue of Acta Gastroenterologica Belgica, summarizing the scientific evidence in favour as well as the limitations of fecal occult blood tests, flexible sigmoidoscopy, videocolonoscopy and virtual colonoscopy.

引用

页码：239 / 240

页数：2

共 12 条

[1]

[Anonymous], 1998, GASTROENTEROL CLIN B, V22, pS1

[2]

Buset M, 2003, ACTA GASTRO-ENT BELG, V66, P20

[3]

Colin JF, 2001, ACTA GASTRO-ENT BELG, V64, P255

[4]

de Visser M, 2005, CELL ONCOL, V27, P17